Use of analog vs human insulin in patients receiving hemodialysis is associated with a lower risk for major adverse cardiovascular events, hospitalization, and death. Treatment with analog rather than ...

(HealthDay News) — For patients with type 2 diabetes, the risk of acute myocardial infarction (AMI) is not significantly different for long-acting insulin analogs versus other basal insulin therapies, ...

These second-generation basal insulin analogs, Gla-300 and IDeg-100, also had similar safety profiles, investigators found. A new study of second-generation basal insulin analogs shows insulin ...

Six years after Gov. Gavin Newsom announced California would get into the prescription drug business and create its own insulin, lower-cost state-branded insulin will finally be available starting in ...

ORLANDO -- For type 1 diabetes patients, switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza) maintained glycemic control -- for those who used it as intended, the ...

Two long-acting insulin analogs have been developed for use as "basal" components of insulin treatment regimens: glargine and detemir. (Insulin glargine has US Food and Drug Administration [FDA] ...

Intensive therapy should achieve glycemic control while avoiding severe and nocturnal hypoglycemia as much as possible. Physiologic, behavioral, and pharmacologic factors contribute to nocturnal ...

A Prescription Drug User Fee Act target date of May 29, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License ...